By Sabela Ojea Shares of Monopar Therapeutics on Tuesday rose sharply after the company said it received clearance in Australia to begin a phase 1 dosimetry.
By Colin Kellaher Shares of RAPT Therapeutics plummeted more than 65% in premarket trading Tuesday after a serious adverse event prompted the U.S. Food and.